Inhibition of the monocyte chemiluminescent response to anti-D-sensitized red cells by FcγRI-blocking antibodies which ameliorate the severity of haemolytic disease of the newborn

Vox Sanguinis

Volumn 70, Issue 3, 1996, Pages 157-163

  Shepard, S L ^a   Noble, A L ^a   Filbey, D ^b   Hadley, A G ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b Blodcentralen   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; FC RECEPTOR; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN G ANTIBODY; RHESUS D ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; MONOCYTE; NEWBORN; NEWBORN HEMOLYTIC DISEASE; PRIORITY JOURNAL;

EID: 0029981661     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1996.tb01315.x     Document Type: Article

References (11)

1. Dooren MC, Kuijpers RWAM, Joekes EC, Huiskes E, Goldschmeding R, Overbeeke MAM, von dem Borne AEGK, Engelfriet CP, Ouwehand WH: Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactrve IgG alloantibodies (anti-HLA-DR). Lancet 1992;339:1067-1070.
2. Dooren MC, van Kamp IL, Kanhai HHH, Bennebroek Gravenhorst J. von dem Borne AEGK, Engelfriet CP: Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies in Rh D-haemolytic disease of the newborn. Vox Sang 1993;65:55-58.
3. Kurlander RJ: Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens. J Immunol 1983;131:140-147
4. Neppert J, Marquard F, Mueller-Eckhardt C: Murine monoclonal antibodies and human alloantisera specific for HLA inhibit monocyte phagocytosis of anti-D-sensitized human red blood cells. Eur J Immunol 1985;15:559-563
5. Neppert J, Mueller-Eckhardt G, Heine O: Reduced immune phagocytosis of monocytes from neonates whose mothers produce HLA antibodies. Vox Sang 1988;54:177-180.
6. Neppert J, Kissel K: Protection against immune haemolytie disease of newborn infants by maternal monocyte-reactive IgG alloantibodies. Lancet 1992;339:1481.
7. Kumpel BM, Poole GD, Bradley BA: Human monoclonal anti-Rh(D) antibodies. 1: Their production, serology, quantitation and potential use as blood grouping reagents Br J Haematol 1989;71:125-129.
8. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A: Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens - New tools for genetic analysis Cell 1978;14:9-20.
9. Maddox JF, Bodmer JG: Hybrid human-mouse class II molecules: Localization of antibody binding sites; in Dupont B (ed): Immunobiology of HLA. vol II: Immunogenetics and Histocompatibility. Berlin, Springer 1989, pp 373-375.
10. Hadley AG, Kumpel BM, Merry AH: The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies. Clin Lab Haematol 1988;10:377-384.
11. Hadley AG, Poole GD, Fraser ID: Predicting the severity of haemolytic disease of the newborn: Prospective evaluation of the chemiluminescence test. Vox Sang 1992;63:291-292.